Edition:
United Kingdom

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

3.72EUR
11 Dec 2017
Change (% chg)

€-0.12 (-3.05%)
Prev Close
€3.84
Open
€3.88
Day's High
€3.88
Day's Low
€3.72
Volume
153,232
Avg. Vol
119,477
52-wk High
€5.78
52-wk Low
€3.63

Latest Key Developments (Source: Significant Developments)

MDxHealth teams up with Ferrer for distribution of its prostate cancer test SelectMDx in Spain
Monday, 20 Nov 2017 

Nov 20 (Reuters) - MDXHEALTH SA : :REG-MDXHEALTH TEAMS UP WITH PHARMACEUTICAL COMPANY FERRER FOR DISTRIBUTION OF ITS PROSTATE CANCER TEST SELECTMDX IN SPAIN.‍UNDER TERMS OF THIS FIVE-YEAR EXCLUSIVE AGREEMENT, A TEAM OF 10 REPS FROM FERRER'S SALES FORCE OF ARE GOING TO SELL SELECTMDX TEST DIRECTLY TO 1000 UROLOGISTS IN SPAIN​.  Full Article

MDxHealth 9M total revenue at 30.5 million dollars
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - MDXHEALTH SA :9M (NOT Q3) NET LOSS $‍​7.4 MILLION VERSUS LOSS OF $10.3 MILLION YEAR AGO.CASH AND CASH EQUIVALENTS ON SEPTEMBER 30, 2017 OF $22.9 MILLION.9M TOTAL REVENUE OF $30.5 MLN‍​.9M EBITDA IMPROVED BY 34.1% FROM $-6.2 MILLION COMPARED TO $-9.1 MILLION IN 2016‍​.TARGETS LOWER END OF ITS 55%-75% PRODUCT AND SERVICE REVENUE GROWTH GUIDANCE FOR 2017.2017 TOTAL REVENUE IS EXPECTED TO GROW BY APPROXIMATELY 60%-70%, TO $48-$51 MILLION.EXPECTS TO MAINTAIN A BALANCE OF CASH AND CASH EQUIVALENTS OF APPROXIMATELY $15 MILLION AT THE END OF 2017.  Full Article

MDxhealth enters distribution agreement with Unilabs for SelectMDx
Monday, 30 Oct 2017 

Oct 30 (Reuters) - MDXHEALTH SA ::‍MDXHEALTH ENTERS INTO DISTRIBUTION AGREEMENT WITH UNILABS FOR SELECTMDX FOR PROSTATE CANCER.​.  Full Article

MDxHealth and Queensland University of Technology collaborate on oral cancer liquid biopsy test
Monday, 19 Jun 2017 

June 19 (Reuters) - MDXHEALTH SA ::REG-MDXHEALTH AND QUEENSLAND UNIVERSITY OF TECHNOLOGY COLLABORATE ON ORAL CANCER LIQUID BIOPSY TEST.SIGNED SCIENTIFIC AGREEMENT WITH QUT BLUEBOX TO DEVELOP LIQUID BIOPSY EPIGENETIC ASSAY FOR EARLY DETECTION OF ORAL CANCER.  Full Article

MDxHealth signs distribution agreement with SouthGenetics
Tuesday, 4 Oct 2016 

MDxHealth SA :Announces agreement with SouthGenetics for distribution of SelectMDx in Central and South America.  Full Article

MDxHealth signs distribution agreement in Poland
Wednesday, 28 Sep 2016 

MDxHealth SA :MDxHealth and the European Health Centre Innovation sign distribution agreement for SelectMDx and ConfirmMDx in Poland.  Full Article

MDxHealth announces upgraded revenue forecast
Thursday, 22 Sep 2016 

MDxHealth SA : MDxHealth announces upgraded revenue forecast . Revenue for year is expected to exhibit growth of more than 60 pct over previous year, compared with prior guidance predicting growth of 30-50 pct . Company maintains its guidance that underlying earnings before interest, taxes, depreciation and amortization (EBIDTA) for year ended 2016 are expected to improve compared to 2015 .Improved performance since the Company's last update can be attributed to accelerated adoption of the Company's ConfirmMDx for prostate cancer test by Urologists in the U.S..  Full Article

MDxHealth gets Medi-Cal Approval for ConfirmMDx
Tuesday, 6 Sep 2016 

Mdxhealth SA :Announced that ConfirmMDx for prostate cancer test is now available as an in-network benefit under California Medical Assistance Program (Medi-Cal).  Full Article

MDxHealth and Teva Pharmaceuticals sign distribution deal
Wednesday, 31 Aug 2016 

Mdxhealth SA : MDxHealth and Teva Pharmaceuticals sign distribution agreement for SelectMDx in Israel .Teva Pharmaceuticals will be exclusive distributor of selectMDx for prostate cancer test in Israel.  Full Article

Mdxhealth and Teva sign distribution agreement for selectMDX in Israel
Wednesday, 31 Aug 2016 

Mdxhealth SA :Mdxhealth and Teva pharmaceuticals sign distribution agreement for selectMDX in Israel.  Full Article

BRIEF-MDxHealth teams up with Ferrer for distribution of its prostate cancer test SelectMDx in Spain

* REG-MDXHEALTH TEAMS UP WITH PHARMACEUTICAL COMPANY FERRER FOR DISTRIBUTION OF ITS PROSTATE CANCER TEST SELECTMDX IN SPAIN